作者前言
【朝花夕拾】几位《“诺光灯”下的科学史掠影》系列文章的热心读者最近问我,从2006年开始在网上BBS论坛对诺奖预测的兴趣是否受了饶毅教授的影响。其实我当年在霍普金斯医学院读博期间,就喜欢与其他研究生和博士后午饭聊天时预测诺奖,那时候还不知道饶教授。2002年饶教授发表了这篇著名的生理或医学奖预测文章,我读后感觉与他很有共鸣,于是决定逐渐把这个与他共同的业余爱好从线下转到线上。
作者:饶毅(写于2002年10月6日)
每年十月,是诺贝尔奖宣布获奖人的季节。2002年诺贝尔生理或医学奖在10月7日宣布。虽然评选委员会以外的人不能预计谁当年会得奖,一般来说,有相当一些人自己有判断,哪些人及其工作值得获奖。
(备注:以下内容中蓝色部分为徐博士的点评)
Elizabeth Blackburn(美国旧金山加州大学UCSF)和Carol Greider(美国霍普金斯大学Johns Hopkins),端粒子和端粒酶,Blackburn主要发现在UC Berkeley做,Greider那时是她的学生。另外有复旦的留学生余国良在Blackburn实验室做过一些早期工作。
# Discoveries made by Mark Ptashne and Bob Tjian might not reach the threshold of a Nobel prize. Prof. Rao’s prediction for Blackburn & Greider is very solid, but I’d like to add the name Jack Szostak as the co-discoverer of telomerase.
# For tumor suppressor gene (TSG) research to be awarded, Knudson and Weinberg would be a good combination. Knudson was a pioneer to study retinoblastoma and Weinberg’s lab cloned the Rb gene in 1986. W.H. Lee’s paper was published in 1987. Bert Vogelstein may or may not be included, I’ll say more likely not for two reasons: (1) Although Arnold Levine’s original work on p53 had errors, he’s still recognized the pioneer of the p53 discovery. Given the time precedence of Rb cloning, the Nobel Committee might pass over p53; (2) Vogelstein’s lab has a Varmus-like co-PI Ken Kinzler, this might also complicate the picture of narrowing down to 3 laureates.
# Animal cloning is too early to be considered a Nobel prize.
# If I remember correctly, the discovery of MHC has already been awarded a Nobel. Why another one for the structure of MHC? Membrane proteins are difficult to crystalize, but pioneering structural determination of the photosynthetic center has already been awarded. So I don’t think this area has a fair chance.
# No way for PKC and IP3 to be awarded after several prizes have already covered the field of signal transduction.
Aaron Ciechanover(以色列工学院Technion),Avram Hershko(以色列工学院Technion),Alexander Varshavsky(美国加州理工学院Caltech),发现蛋白质降解的生物化学机理。
# The field of ubiquitin and proteasome is very close to my heart! Based on my personal bias (my Ph.D. thesis was on small ubiquitin-like proteins), I wish a ubiquitin Nobel will happen soon, most likely as a Chemistry prize.
Tim Bliss(英国)和Terje Lomo(挪威),发现长期性增强作用(LTP),推动高等动物学习记忆研究。这项奖,受Eric Kandel近年刚因为研究低等动物(海兔)学习记忆得奖而可能推后。
Apprentice to Genius(英文原版和中文译本的封面)
小编导读
本文的中文版本准备中,将于近期发表。欢迎朋友们关注!多谢!
推荐阅读
-
从Aducanumab到GV-971,人类能跳出阿尔兹海默症这座“五指山”吗? -
从横空出世到领跑眼科创新药,揭开欧康维视临床研发神秘面纱 ——访欧康维视首席医学官陈冬红博士 -
极目生物宣布引进FDA批准干眼治疗器械大中华区、韩国及东盟十国独家权益 -
里程碑!渤健/卫材阿尔兹海默症新药Aducanumab获FDA批准上市,十年磨一剑! -
药时代直播间67期 | 对话强生创新:探索肿瘤免疫疗法趋势与合作 -
肿瘤治疗新纪元,还有哪些领域在蓄势待发? -
六院士齐聚张江有话说|这里还有张文宏主任、朱剑虹会长、Christian Brechot主席、郝捷主任。。 -
豪森药业license-in新突破!抗真菌创新药BREXAFEMME ® (ibrexafungerp)已获美国FDA批准 -
中国好投资人 | 高瓴资本 -
科兴疫苗成为国内第二款获WHO批准紧急使用新冠疫苗,下一个花落谁家? -
股价腰斩!400亿美元市场何时才能迎来首款治疗药物?NASH以及值得期待的下半年 -
中国好合伙人|同筑新药梦,共创大未来! -
First-in-Class!与药时代大咖共进午餐,您准备好了吗?
本篇文章来源于微信公众号:药时代
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权